GSK3β's Role in Breast Cancer Cell Death from Trichostatin A
Author Information
Author(s): Alao John P, Stavropoulou Alexandra V, Lam Eric W-F, Coombes R Charles
Primary Institution: Department of Cell and Molecular Biology, Lundberg Laboratory, Gothenburg University; Department of Cancer Medicine, Cancer Cell Biology Section, Imperial College
Hypothesis
Does GSK3β mediate the cytotoxic effects of trichostatin A in MCF-7 breast cancer cells?
Conclusion
GSK3β is an important mediator of TSA-induced cytotoxicity in MCF-7 breast cancer cells.
Supporting Evidence
- TSA treatment led to dephosphorylation of Akt and GSK3β in MCF-7 cells.
- Selective inhibition of GSK3β reduced TSA-induced cytotoxicity.
- Knockdown of GSK3β increased cell survival after TSA treatment.
Takeaway
This study found that a drug called trichostatin A can make breast cancer cells die, and a protein called GSK3β helps this happen.
Methodology
MCF-7 breast cancer cells were treated with trichostatin A and various inhibitors, followed by analysis of protein phosphorylation and cell survival.
Limitations
The study primarily focuses on one cell line and may not generalize to other cancer types.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website